Emerging Technologies and Future Directions in Interorgan Crosstalk Cardiometabolic Research

作者：Hosung Bae, Christy M Nguyen, Jorge Ruiz‐Orera, Nicholas L. Mills, M Snyder, Cholsoon Jang, Svati H. Shah, Norbert Hübner, Marcus Seldin · 发表于：Circulation Research · 年份：2025 · DOI：10.1161/circresaha.125.325515 · 被引用次数：12 · 研究领域：Pancreatic function and diabetes、Receptor Mechanisms and Signaling、Adipose Tissue and Metabolism

The heart does not work in isolation, with cardiac health and disease occurring through complex interactions between the heart with multiple organs. Furthermore, the integration of organ-specific lipid metabolism, blood pressure, insulin sensitivity, and inflammation involves a complex network of signaling pathways between many organs. Dysregulation in these communications is now recognized as a key contributor to many manifestations of cardiovascular disease. Mechanistic characterization of specific molecules mediating interorgan signaling has been pivotal in advancing our understanding of cardiovascular disease. The discovery of insulin, glucagon, and other hormones in the early 20th century illustrated the importance of communication between organs in maintaining physiological homeostasis. For example, elegant studies evaluating insulin signaling and its role in regulating glucose metabolism have shed light on its broader impact on cardiovascular health, hypertension, atherosclerosis, and other cardiovascular disease risks. Recent technological advances have revolutionized our understanding of interorgan signaling. Global approaches such as proteomics and metabolomics applications to blood have enabled the simultaneous profiling of thousands of circulating factors, revealing previously unknown signaling molecules and pathways. These large-scale studies have identified biomarkers linked to early stages of heart disease and offered new therapeutic targets. By understanding h...